The Norwegian Radiumhospital

Oslo NO-0310

1 studies enrolling now · 5 studies all time

What they study most

Endometrial Cancer, Follicular Lymphoma, Malignant Melanoma, Neoplasm Metastasis, Non-Hodgkin Lymphoma, Ovarian Cancer, Peritoneal Carcinomatosis

Studies at this site

• A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery — Recruiting now
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed
• Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer — Completed
• Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma — Completed
• Clinical Study of Previously Untreated Patients With Malignant Melanoma — Completed